Compare GameStop Corp. (GME) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GameStop Corp. vs Repligen Corporation Common Stock — how do they compare? GameStop Corp. trades at $26.45 (market cap $13.73B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: GameStop Corp. is the larger of the two by market cap, and GameStop Corp. is more actively traded (12,710,661 versus 1,259,263). Which is the better fit depends on your goals — on Pluang, investors hold GameStop Corp. for 62 Days and Repligen Corporation Common Stock for 0 Days on average.
| GME | RGEN | |
|---|---|---|
Market Cap | $13.73B | $11.14B |
Volume | 12,710,661 | 1,259,263 |
Sector | Consumer Cyclical | Health |
52-Week High | $27.23 | $194.57 |
52-Week Low | $17.87 | $102.87 |
Typical Hold Time | 62 Days | 0 Days |
Enterprise Value | $13.01B | $11.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GME trades at $27.15, down 0.29% on the day, with a bullish technical signal supported by moving averages. The company reported net income of $131.3M in 2025, a significant turnaround from prior losses, and holds a strong cash position of $4.77B. Recent insider buying by CEO Ryan Cohen has driven positive sentiment, with shares gaining 31% over the past month.
The outlook is mixed; strong cash reserves and insider confidence support upside, but revenue declined to $3.82B in 2025, and analyst consensus remains cautious with only 16.7% buy ratings. Key risks include execution challenges in the retail gaming sector and high valuation multiples relative to historical performance.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GameStop Corp.
Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.
Read more on GME →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
